So-Young International Inc. Sponsored ADR

SY Healthcare Health Information Services

So-Young International Inc. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $217.8 million, up 8.41% from fiscal 2024.

Revenue
+40.8%
EPS
+40.0%
Free cash flow
−798.4%
Total debt
+99.7%

Quarter to June 2026, against a year earlier

2.06 0.03 −1.44%
Market cap
$177.7M
P/E
0.0×
Fwd P/E
12.8×
Dividend yield
0.00%
F-score
5/9
Altman Z
1.02
Beneish M
−2.96
Dividend safety
20/100

Insider Decisions last twelve months

Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 23.97%

Capital & Financial Ratios $m

Size
Market Cap 177.67
Revenue ttm 261.21
Net income ttm (35.31)
Free cash flow ttm (77.88)
Net debt Q (108.33)
Valuation
P/E 0.00
Forward P/E 12.80
Price / sales 0.81
Forward P/S Powerpack
Price / FCF 0.00
Price / book 0.91
Financial health
Current ratio Q 1.61 (at or above 1.5: strong)
Debt / equity Q 0.07 (at or below 0.5: strong)
Interest coverage Q —
Growth
Revenue growth Q +40.84% (above 0%: growing)
Operating income growth Q +2.19% (above 0%: growing)
EPS, this year +50.14% (at or above 15%: strong)
EPS, next year A +85.45% (at or above 15%: strong)
Revenue, next year A +41.37% (at or above 10%: strong)
EPS, past 5 yrs —
EPS, next 5 yrs A +65.07% (at or above 15%: strong)

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

P/S against its own 10 years 41.41%
10-year low 10-year high
P/B against its own 10 years 50.95%
10-year low 10-year high
EV/Sales against its own 10 years 17.10%
10-year low 10-year high

Dividends

Yield
0.00%
Annual rate
0.00
Payout ratio
—
Growth, 2024–25
−100.0%/yr
  1. 0.06 ’24
  2. 0.00 ’25 −100
paid change on the year, %

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 189 172 134 125
Receivables 13 17 10 10
Inventory 17 21 33 37
Other — — — —
243 236 212 216
2023 2024 2025 Q'26
Payables — — — —
ST’ Debt 4 10 6 17
Other 15 10 9 9
76 86 112 134

Compound Annual Growth %

10y 5y 3y
Sales — 1.88% 6.10%
Cash Flow — 0.00% 0.00%
Earnings — 0.00% 0.00%
Book Value — (9.72%) (14.22%)

EPS $

Mar Jun Sep Dec Year
’26 (0.07) (0.03) — — —
’25 (0.04) (0.05) (0.09) (0.15) (0.34)
’24 (0.03) 0.02 0.03 (0.81) (0.78)
’23 (0.02) 0.00 0.02 0.03 0.03
’22 (0.10) (0.04) 0.00 0.04 (0.09)
’21 (0.06) 0.08 0.01 (0.04) (0.01)
’20 (0.05) 0.00 0.00 0.05 0.01
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 63 74 — — —
’25 41 53 54 70 218
’24 44 56 53 48 201
’23 45 57 53 56 211
’22 47 46 45 43 182
’21 55 70 67 74 266
’20 26 46 53 73 198
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 — — — — —
’25 — — — — (15)
’24 — — — — (4)
’23 — — — — 3
’22 — — — — (16)
’21 — — — — 13
’20 — — — — 27
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 — — — — —
’25 — — — (43) (43)
’24 — — — (12) (12)
’23 — — — (4) (4)
’22 — — — (19) (19)
’21 — — — 6 6
’20 — — — 22 22
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Jun ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue 7 38 90 165 198 266 182 211 201 218 261 +45.6% 308 419 547 +35.9%
Gross margin, % 48.68 82.72 85.17 82.75 83.61 80.63 68.73 63.66 61.30 47.77 44.43 (0.9) pt
EBT (11) 3 8 33 0 (3) (13) 1 (81) (35) (37) +13.6%
EBT margin, % (151.53) 6.58 9.44 19.66 0.01 (0.97) (6.92) 0.53 (40.10) (16.16) (14.24) +135.4 pt
Net income (15) 0 8 25 1 (6) (10) 4 (80) (35) (35) +9.6%
Per share, $
Per share, $ Revenue 0.07 0.38 2.81 2.14 3.16 2.50 1.70 2.72 1.95 2.15 2.58 +45.5%
Earnings (0.20) (0.02) (0.22) 0.24 0.01 (0.01) (0.09) 0.03 (0.78) (0.34) (0.34) +6.1%
Cash flow (0.06) 0.13 0.91 0.71 0.44 0.12 (0.15) 0.04 (0.03) (0.15) 0.00 +10.4%
Capex 0.00 0.00 (0.03) (0.07) (0.09) (0.07) (0.02) (0.09) (0.08) (0.28) 0.00 n/m
Free cash flow (0.06) 0.13 0.88 0.64 0.35 0.06 (0.17) (0.05) (0.12) (0.43) 0.00 +24.1%
Book value 0.00 0.65 (1.63) 4.92 6.34 3.72 3.52 4.65 2.60 2.36 2.30 n/m
Shares, m 100 100 32 77 63 106 107 78 103 101 101 +0.1%
Valuation, ×
Valuation, × P/E 0.00 0.00 455.00 58.19 787.94 0.00 0.00 41.67 0.00 0.00 0.00 134.3
P/S 0.00 0.00 0.00 5.70 3.51 1.28 0.85 0.59 0.43 1.19 0.81 1.4
P/B 0.00 0.00 0.00 2.48 1.75 0.86 0.41 0.35 0.32 1.09 0.91 0.7
EV/Sales 0.00 0.00 0.00 3.26 1.48 0.26 (0.37) (0.28) (0.38) 0.60 0.40 0.5
EV/FCF 0.00 0.00 0.00 0.00 0.00 0.66 (1.13) (11.17) 2.68 (1.68) (1.34) (1.1)
Cash, $m
Cash, $m Operating cash flow (6) 13 29 55 27 13 (16) 3 (4) (15) (32) +10.5%
Capex 0 0 (1) (5) (6) (7) (2) (7) (9) (28) (46) +81.1%
Free cash flow (6) 13 28 50 22 6 (19) (4) (12) (43) (78) +24.2%
Balance, $m
Balance, $m Working capital — 63 142 358 341 206 200 166 150 100 82 +5.9%
Net debt — (80) (176) (403) (404) (269) (223) (185) (162) (128) (108) +6.0%
Shareholders’ equity — 66 (52) 380 398 395 378 361 268 239 232 +17.5%
Returns, %
Returns, % ROA 0.00 (1.19) (7.33) 5.51 0.18 (0.26) (1.93) 0.65 (19.52) (9.20) (9.29) (9.2) pt
ROIC — 0.00 0.00 0.00 0.00 (2.53) (5.99) (3.05) (50.34) (23.16) (21.77) (23.2) pt
ROE 0.00 4.31 18.40 11.09 0.23 (0.33) (2.46) 0.81 (25.68) (13.67) (14.44) (13.7) pt
People
People Employees — — 862 1,218 1,564 2,085 1,573 1,357 1,800 2,348 — +15.4%
Revenue/emp, $m 0.00 0.00 0.10 0.14 0.13 0.13 0.12 0.16 0.11 0.09 — n/m
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026 · fundamentals updated 2 Nov 2026

So-Young International Inc. Sponsored ADR vs peers in Health Information Services (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
CTEV Claritev Corporation $342.7M — (loss-making) — (loss-making) +6.59% (above 0%: growing) n/m +49.10% (above 0%: growing) 73.72% 9.09% Compare
SPOK Spok Holdings, Inc. $245.9M 12.9× 16.2× −2.56% (below 0%: shrinking) +190.31% (above 0%: growing) +61.57% (above 0%: growing) 79.66% 17.08% Compare
AMWL American Well Corporation $208.5M — (loss-making) — (loss-making) −12.96% (below 0%: shrinking) n/m +21.98% (above 0%: growing) 52.99% (23.79%) Compare
SY So-Young International Inc. Sponsored ADR $177.7M — (loss-making) 12.8× +40.84% (above 0%: growing) n/m −798.37% (below 0%: shrinking) 44.11% (8.64%)
DH Definitive Healthcare Corp. $163.7M — (loss-making) — (loss-making) −8.99% (below 0%: shrinking) n/m −32.60% (below 0%: shrinking) 77.27% (9.09%) Compare
OPRX OptimizeRx Corp. $163.3M 35.8× 41.7× −29.77% (below 0%: shrinking) n/m +89.86% (above 0%: growing) 76.51% (0.43%) Compare
HCAT Health Catalyst, Inc. $112.9M — (loss-making) — (loss-making) −26.26% (below 0%: shrinking) n/m +65.58% (above 0%: growing) 42.71% 89.08% Compare
LFMD LifeMD, Inc. $110.4M — (loss-making) — (loss-making) −3.55% (below 0%: shrinking) n/m −247.52% (below 0%: shrinking) 88.82% (15.08%) Compare
CCLD CareCloud, Inc. $91.8M 16.5× 11.0× +8.56% (above 0%: growing) +150.00% (above 0%: growing) −0.44% (below 0%: shrinking) 50.46% 19.50% Compare
Median of peers $163.5M 16.5× 16.2× −6.27% — +35.54% 75.12% 4.33%

All 44 Health Information Services stocks →

So-Young International Inc. Sponsored ADR (SY) Latest News

31 Aug

13 Feb

Impact 3 · · Simply Wall St.

11 Dec

Impact 4 · · Simply Wall St.

4 Nov

Impact 4 · · Simply Wall St.

18 Aug

Impact 2 · · PR Newswire
stockrow.com/SY · Data as of Nov 2, 2026 · For information only; not investment advice. · © 2026 stockrow.com